HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsOxi-4503
Chemical structure of CAS 288847-35-8

Oxi-4503

In Stock•Starting at $829 for 1 mg•Purity ≥ 98%
CAS No.288847-35-8
MDL No.N/A
MFC18H22O12P2
MW492.30
InChI KeyGSOXMQLWUDQTNT-WAYWQWQTSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98.00%$829In Stock
5 mg98.00%$2057In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.288847-35-8
Product NameOxi-4503

Associated Conditions

neoplasm·acute myeloid leukemia·myelodysplastic syndrome
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Alterations in vascular architecture and permeability following OXi4503 treatment.

Anti-cancer drugs • Vol. 19, Issue 1 • 2008
PMID: 18043126DOI: 10.1097/CAD.0b013e3282f077a1

Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.

Anticancer research • Vol. 27, Issue 4B • 2007
PMID: 17695520

The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group • Vol. 23, Issue 7 • 2007
PMID: 18038290DOI: 10.1080/02656730701739554

Effect of the second-generation vascular disrupting agent OXi4503 on tumor vascularity.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 12, Issue 13 • 2006
PMID: 16818709DOI: 10.1158/1078-0432.CCR-06-0163

Documentation

Similar Products